NCT02239133View on ClinicalTrials.gov

R&D Supporting Pilot Study for the Assessment of the Safety and Effectiveness of the ProVATE (ProTIPI) Vaginal Pessary

NAUnknownINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Pelvic Organ Prolapse

Interventions

DEVICE

ProVATE vaginal pessary

Trial Locations (3)

Unknown

Site 01, Herzliya

Site 02, Herzliya

Site 03, Ramat HaSharon

Sponsors

Lead Sponsor

ConTIPI Medical

All Listed Sponsors

lead

ConTIPI Medical

INDUSTRY